Abstract

Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel

Author(s): Allen Loyd V Jr

Issue: Nov/Dec 2008 - Arthritis and Immunological Diseases

Page(s): 540

Download in electronic PDF format for $75
  • Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel Page 1

Abstract

A formulation for preparing Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords

  • cyclobenzaprine hydrochloride
  • diclofenac sodium
  • topical preparations
  • transdermal administration
  • pain relief
  • pain control
  • analgesia
  • analgesic
  • formulation
  • nonsteroidal anti-inflammatory drugs
  • NSAIDs

Related Categories

  • FORMULATIONS
  • PAIN MANAGEMENT
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Nov/Dec 2008
Pg. 540
Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
May/Jun 2011
Pg. 245
Ketoprofen 10%, Ibuprofen 10%, Cyclobenzaprine Hydrochloride 2%, and Piroxicam 2% in Pluronic Lecithin Organogel Gel
Author(s): Allen Loyd V Jr
Mar/Apr 2015
Pg. 161-166
Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations
Author(s): Bryson Evan, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott
May/Jun 2010
Pg. 200-203
Topical Medications for Orofacial Neuropathic Pain
Author(s): Bramwell Bethany L
Nov/Dec 2008
Pg. 541
Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel
Author(s): Allen Loyd V Jr
May/Jun 2010
Pg. 182-192
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome
Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2013
Pg. 247-253
Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel
Author(s): Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
May/Jun 2014
Pg. 256-261
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery
Author(s): Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
May/Jun 2009
Pg. 245
Oxycodone Hydrochloride 10 mg/mL in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
May/Jun 2011
Pg. 243
Diclofenac Sodium 1% Topical Gel
Author(s): Allen Loyd V Jr
Mar/Apr 2024
Pg. 100-109
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Nov/Dec 2010
Pg. 512
Amitriptyline Hydrochloride 2%, Baclofen 5%, Ketamine Hydrochloride 5%, Ketoprofen 10% in Pluronic Lecithin Organogel
Author(s): Allen Loyd V Jr
Jul/Aug 2014
Pg. 278-286
Compounded Pain Formulations: What is the Evidence?
Author(s): Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
Jan/Feb 2022
Pg. 65-71
Physical Stability and Release Profile of Compounded Gabapentin Containing Pluronic Lecithin Organogel for Neuropathic Pain Management
Author(s): Hong Eun Ji, Sumanasekera Wasana, Le Uyen Minh
Sep/Oct 2007
Pg. 421
Diclofenac Sodium 75-mg/mL Injection
Author(s): Allen Loyd V Jr
May/Jun 2010
Pg. 204-206
Managing Pain with Transdermal Ketoprofen
Author(s): Williams KaCee D
Mar/Apr 2024
Pg. 134
Diclofenac Sodium 1% Soft-patch Gel
Author(s): Allen Loyd V Jr
Jan/Feb 2008
Pg. 65
Diclofenac Sodium 1% Soft-Patch Gel
Author(s): Allen Loyd V Jr
Jan/Feb 2008
Pg. 66
Diclofenac Sodium 1% Soft-Patch Lipophilic Gel
Author(s): Allen Loyd V Jr